Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-10,475
Closed -$494K 43
2015
Q3
$494K Hold
10,475
0.84% 53
2015
Q2
$569K Hold
10,475
0.89% 51
2015
Q1
$575K Sell
10,475
-17,838
-63% -$1.01M 0.88% 37
2014
Q4
$1.53M Sell
28,313
-4,904
-15% -$273K 0.91% 35
2014
Q3
$1.88M Buy
33,217
+191
+0.6% +$10.7K 0.99% 34
2014
Q2
$1.82M Buy
33,026
+499
+2% +$27.2K 0.94% 38
2014
Q1
$1.76M Sell
32,527
-3,494
-10% -$181K 0.96% 38
2013
Q4
$1.72M Buy
36,021
+5,928
+20% +$271K 0.88% 41
2013
Q3
$1.37M Sell
30,093
-4,485
-13% -$205K 0.91% 37
2013
Q2
$1.53M Buy
+34,578
New +$1.54M 0.93% 40

Other funds holding MRK

Cinque Partners's MRK Position: Q4 2015 in Review

Cinque Partners sold out of Merck (MRK) in Q4 2015, closing a stake of 10,475 shares — an estimated $494K sold.

Cinque Partners first reported a position in MRK in Q2 2013 and held it in 10 quarters. The position peaked at $1.88M in Q3 2014. 1,754 funds tracked by Wall St. Rank hold MRK as of Q4 2015.

  • Cinque Partners reported no remaining Merck position as of Q4 2015 after selling out during the quarter.
  • Cinque Partners sold 10,475 Merck shares in Q4 2015, an estimated $494K.
  • Cinque Partners first reported a position in Merck in Q2 2013 and held it in 10 quarters.
  • Cinque Partners's Merck position peaked at $1.88M in Q3 2014.
  • 1,754 funds tracked by Wall St. Rank held Merck as of Q4 2015.

Based on Cinque Partners's 13F filing for Q4 2015, filed 12 Feb 2016.